These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 25473945)
1. Prospective evaluation of teleophthalmology in screening and recurrence monitoring of neovascular age-related macular degeneration: a randomized clinical trial. Li B; Powell AM; Hooper PL; Sheidow TG JAMA Ophthalmol; 2015 Mar; 133(3):276-82. PubMed ID: 25473945 [TBL] [Abstract][Full Text] [Related]
2. Qualifying to Use a Home Monitoring Device for Detection of Neovascular Age-Related Macular Degeneration. Thomas M; Wolfson Y; Zayit-Soudry S; Bressler SB; Bressler NM JAMA Ophthalmol; 2015 Dec; 133(12):1425-30. PubMed ID: 26468999 [TBL] [Abstract][Full Text] [Related]
5. Ranibizumab versus Bevacizumab for Neovascular Age-related Macular Degeneration: Results from the GEFAL Noninferiority Randomized Trial. Kodjikian L; Souied EH; Mimoun G; Mauget-Faÿsse M; Behar-Cohen F; Decullier E; Huot L; Aulagner G; Ophthalmology; 2013 Nov; 120(11):2300-9. PubMed ID: 23916488 [TBL] [Abstract][Full Text] [Related]
6. Optometric referrals to retina specialists: evaluation and triage via teleophthalmology. Hanson C; Tennant MT; Rudnisky CJ Telemed J E Health; 2008 Jun; 14(5):441-5. PubMed ID: 18578678 [TBL] [Abstract][Full Text] [Related]
7. Bevacizumab for neovascular age-related macular degeneration in China. Li X; Hu Y; Sun X; Zhang J; Zhang M; Ophthalmology; 2012 Oct; 119(10):2087-93. PubMed ID: 22818896 [TBL] [Abstract][Full Text] [Related]
8. Age-related macular degeneration and risk factors for the development of choroidal neovascularisation in the fellow eye: a 3-year follow-up study. Silva R; Cachulo ML; Fonseca P; Bernardes R; Nunes S; Vilhena N; Faria de Abreu JR Ophthalmologica; 2011; 226(3):110-8. PubMed ID: 21822000 [TBL] [Abstract][Full Text] [Related]
9. Morphologic parameters relevant for visual outcome during anti-angiogenic therapy of neovascular age-related macular degeneration. Simader C; Ritter M; Bolz M; Deák GG; Mayr-Sponer U; Golbaz I; Kundi M; Schmidt-Erfurth UM Ophthalmology; 2014 Jun; 121(6):1237-45. PubMed ID: 24684838 [TBL] [Abstract][Full Text] [Related]
10. Clinical utilization of anti-VEGF agents and disease monitoring in neovascular age-related macular degeneration. Holekamp NM; Liu Y; Yeh WS; Chia Y; Kiss S; Almony A; Kowalski JW Am J Ophthalmol; 2014 Apr; 157(4):825-833.e1. PubMed ID: 24388973 [TBL] [Abstract][Full Text] [Related]
14. Retreatment with anti-vascular endothelial growth factor therapy based on changes in visual acuity after initial stabilization of neovascular age-related macular degeneration: 3-year follow-up results. Dunavoelgyi R; Sacu S; Eibenberger K; Palkovits S; Leydolt C; Pruente C; Schmidt-Erfurth U Retina; 2012 Sep; 32(8):1471-9. PubMed ID: 22414958 [TBL] [Abstract][Full Text] [Related]
15. An epidemiological study of neovascular age-related macular degeneration in Germany. Krause L; Yousif T; Pohl K; Curr Med Res Opin; 2013 Oct; 29(10):1391-7. PubMed ID: 23944372 [TBL] [Abstract][Full Text] [Related]
16. Disease Burden in the Treatment of Age-Related Macular Degeneration: Findings From a Time-and-Motion Study. Prenner JL; Halperin LS; Rycroft C; Hogue S; Williams Liu Z; Seibert R Am J Ophthalmol; 2015 Oct; 160(4):725-31.e1. PubMed ID: 26142721 [TBL] [Abstract][Full Text] [Related]
17. Management of thick submacular hemorrhage with subretinal tissue plasminogen activator and pneumatic displacement for age-related macular degeneration. Chang W; Garg SJ; Maturi R; Hsu J; Sivalingam A; Gupta SA; Regillo CD; Ho AC Am J Ophthalmol; 2014 Jun; 157(6):1250-7. PubMed ID: 24531021 [TBL] [Abstract][Full Text] [Related]
18. Retinal pigment epithelial cell loss assessed by fundus autofluorescence imaging in neovascular age-related macular degeneration. Kumar N; Mrejen S; Fung AT; Marsiglia M; Loh BK; Spaide RF Ophthalmology; 2013 Feb; 120(2):334-41. PubMed ID: 23137630 [TBL] [Abstract][Full Text] [Related]
19. An evaluation of photographic screening for neovascular age-related macular degeneration. Maberley DA; Isbister C; Mackenzie P; Aralar A Eye (Lond); 2005 Jun; 19(6):611-6. PubMed ID: 15184945 [TBL] [Abstract][Full Text] [Related]
20. Visual acuity and central retinal thickness: fulfilment of retreatment criteria for recurrent neovascular AMD in routine clinical care. Reznicek L; Muhr J; Ulbig M; Kampik A; Mayer WJ; Haritoglou C; Neubauer A; Wolf A Br J Ophthalmol; 2014 Oct; 98(10):1333-7. PubMed ID: 24903670 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]